Villanueva Jonathan, Nishimura Toshinobu, Nakauchi Hiromitsu
Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Methods Mol Biol. 2019;2048:259-264. doi: 10.1007/978-1-4939-9728-2_20.
For scientists working within the field of induced pluripotent stem cells (iPSCs), this protocol will provide a thorough walk-through on how to conduct in vitro and in vivo experiments that validate the function of a particular safeguard system technology. In short, we provide instructions on how to generate inducible Caspase-9 (iC9) safeguard system with human iPSCs that act as normal or abnormal models of the cells for therapeutics to be tried after differentiation. These iC9-iPSCs should be modified prior to beginning this protocol by constitutively expressing luciferase, an enzyme capable of generating bioluminescent signals through the oxidation of the substrate luciferin. Monitoring the bioluminescent signal over time provides the information on whether a safeguard system is working or not.
对于在诱导多能干细胞(iPSC)领域工作的科学家而言,本方案将全面介绍如何进行体外和体内实验,以验证特定保障系统技术的功能。简而言之,我们提供了有关如何利用人类iPSC生成诱导型Caspase-9(iC9)保障系统的说明,这些iPSC可作为正常或异常细胞模型,用于分化后待试验治疗方法。在开始本方案之前,这些iC9-iPSC应通过组成型表达荧光素酶进行修饰,荧光素酶是一种能够通过底物荧光素的氧化产生生物发光信号的酶。随着时间的推移监测生物发光信号可提供保障系统是否起作用的信息。